Treat asiathe asia-pacific region is home to nearly 7 million people living with HIV, the world's largest epidemic after that in eastern and southern africa, with 23% of all new infections globally. Treatment coverage varies significantly across the region, where people living with and at risk for HIV are also challenged by co-infections such as hepatitis, tuberculosis, and mental health issues. W… Read more
Treat asiathe asia-pacific region is home to nearly 7 million people living with HIV, the world's largest epidemic after that in eastern and southern africa, with 23% of all new infections globally. Treatment coverage varies significantly across the region, where people living with and at risk for HIV are also challenged by co-infections such as hepatitis, tuberculosis, and mental health issues. With its network of 21 adult and 18 pediatric sites in 12 countries across the region, amfar's treat asia program brings researchers, health professionals, and advocates together to improve standards of care, expand access to treatment and prevention, and support community-led monitoring of health needs across the region. Championing database-driven researchtreat asia manages the asia-pacific section of the international epidemiology databases to evaluate AIDS (iedea), a global collaboration established by the U.S. National institute of allergy and infectious diseases. Iedea is central to the international research in which treat asia participates, ranging from studies on treatment outcomes, cancer screening, and clinical outcomes of pulmonary tb, to mental health challenges faced by adolescents living with HIV. The information gathered from treat asia's observational research databases continues to inform the development of more effective research and treatment programs and help define treatment standards specific to HIV/AIDS in asia along the continuum of care. These data also inform studies on lymphoma, hepatitis, substance use, and alzheimer's disease, among other conditions. Other major database and cohort studies are focusing on HIV treatment failure; management and outcomes of HIV and tb; and mental health screening and linkage to care strategies.supporting adolescent health researchfor adolescents across southeast asia, who represent about 30% of the global adolescent population, the challenge to stay healthy is compounded by health systems that sometimes lack the capacity to address their needs.in response to these gaps, treat asia, in collaboration with longstanding partner chulalongkorn university's school of global health in bangkok, organized an adolescent health and research meeting, a training workshop designed to strengthen adolescent health services and research capacity across southeast asia, in September 2025.treat asia is a leader in research focused on younger people living with HIV, some of whom acquired HIV perinatally. Studies focused on adolescents living with and at risk for HIV address mental health collaborative care, cannabis use, human papillomavirus and cancer risk, and the associations between risk-taking behavior and brain health. Three multi-year studies are described below.thai-papaya (thai program to actively follow perinatal adolescents and young adults living with HIV): Implemented in five sites in thailand, this study examines long-term HIV treatment outcomes of adolescents and young adults living with HIV, including retention in care, mortality, health-related quality of life, and sexual and reproductive health, among other issues. Sub-studies on cardiovascular disease, stigma around healthcare transitions, and best practices for helping younger people transition into adult care are also being conducted.suicidal behavior among thai adolescents living with HIV (s-betah): This prospective cohort study aims to determine the prevalence of mental health disorders and suicidal behavior following positive screening and linkage to mental health services. A follow-up phase is assessing the prevalence and incidence of suicidality among this population compared with their hiv-negative age- and sex-matched counterparts. Adolescent and young adult network of iedea (ayani): Focusing on adolescents aged 1524 years old, this global study assesses care transitions, co-morbidities, mental health challenges, and factors impacting treatment adherence, viral suppression, care engagement, and mortality. Ten multiregional ayani research concepts are in different stages of completion.hiv, hpv, and cervical cancer: A deadly nexusregular cervical cancer screeningspap smears and testing for human papillomavirus (hpv), the primary cause of cervical cancerhelp detect cancerous and precancerous cells early, when they are most treatable. Low uptake of cervical health screenings, combined with the fact that women living with HIV are susceptible to chronic, persistent high-risk hpv infection (strains more prone to lead to cancer) and are six times more likely to develop cervical cancer than women without HIV, prompted treat asia network investigator dr. Agus somia, of prof. Dr. Ngoerah hospital in bali, indonesia, to study the issue in more depth.the study collected data via interviews and clinical exams at HIV outpatient clinics to determine the prevalence and risk factors of high-risk hpv and cervical dysplasia in women living with HIV. Based on its findings, the study recommends increasing hpv vaccination and cervical cancer screening, particularly for younger women, and screening all women living with HIV in indonesia in order to improve health outcomes.understanding alzheimer's and HIV in asiaalzheimer's diseasea disorder involving progressive degeneration of the brain affecting cognition (memory, thinking, behavior)is the most common form of dementia among the general population, accounting for 60% to 80% of cases. The risk of alzheimer's increases exponentially with age, and that risk increases in people living with HIV, for whom 30% to 50% have some form of cognitive impairment. Accurate diagnosis of alzheimer's is crucial so that physicians can work with patients to manage symptoms, explore treatment options, and improve quality of life.thanks to an amfar-supported study, led by dr. Akarin hiransuthikul, of chulalongkorn university in bangkok, thailand, researchers have shown that a new method of diagnosing alzheimer'sa blood-based biomarkercould be useful in predicting cognitive decline in people living with HIV. Participants were enrolled from cohorts in bangkok, thailand, and kuala lumpur, malaysia.fostering mental health researchthe objective of treat asia's chimera program (capacity development for HIV and mental health research in asia) is to address the dual and interlinked burdens of HIV and mental health. Co-led by principal investigators dr. Annette sohn and dr. Milton wainberg of columbia university, the program aims to build groups of investigators within the asia-pacific with the capacity to lead regional hiv-mental health-implementation science research that informs public health policy and improves clinical care.chimera brings together stellar training faculty from academic centers and public health organizations within the region and across the world, and builds on existing nih-funded mental health research being conducted through iedea asia-pacific. The program was renewed by the nih for another five years in September 2025. A new class of six fellows includes dr. Narom prak (cambodia), dr. Lim quan hziung and preethi raghavan (malaysia), dr. Ruth anne b. Hechanova-cruz (philippines), and drs. Nadvadee aungkawattanapong and mayteewat chiddaycha (thailand). Throughout the year, the fellows made strides in their training activities and are preparing to conduct pilot research studies as part of the curriculum. Sharing research findingstreat asia investigators published 28 scientific papers in peer-reviewed medical journals in 2025. These findings are shared in part through the participation of treat asia in regional and international conferences. Treat asia had a strong presence at the 2025 international AIDS society conference on HIV science in kigali, rwanda, in July 2025, with treat asia staff and partner investigators delivering 12 posters and presentations on topics ranging from prep and medication adherence to kidney dysfunction and mental health service integration. Abstracts were also presented at the international workshop on HIV, srhr, & adolescence (October 2024), the conference on retroviruses and opportunistic infections (March 2025), and the asia-pacific AIDS and co-infections conference (June 2025), among others.